Skip to main content
Log in

Lamivudine monotherapy best bet in preventing HBV recurrence

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Dan YY, Wai CT, Yeoh KG, Lim SG.Prophylactic strategies for hepatitis B patients undergoing liver transplant: a cost-effectiveness analysis. Liver Transplantation 12: 736-746, No. 5, May 2006

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lamivudine monotherapy best bet in preventing HBV recurrence. Pharmacoecon. Outcomes News 508, 4 (2006). https://doi.org/10.2165/00151234-200605080-00011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200605080-00011

Keywords

Navigation